Secondary prevention of stroke - Results from the Southern Africa Stroke Prevention Initiative (SASPI) study

Bulletin of the World Health Organization

Volumn 82, Issue 7, 2004, Pages 503-508

  Thorogood, Margaret ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Antihypertensive agents therapeutic use; Cerebrovascular accident diagnosis therapy; Ethnic groups psychology; Health knowledge, attitudes, practice; Hypertension epidemiology therapy; Patient acceptance of health care ethnology; Risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT;

CARDIOVASCULAR DISEASE; HEALTH CARE; HYPERTENSION; RISK FACTOR;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CIGARETTE SMOKING; DIAGNOSTIC APPROACH ROUTE; ETHNOLOGY; EXPERIENCE; FAMILY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; NURSE; PHYSICIAN; PILL; PREVALENCE; PRIMARY MEDICAL CARE; RECURRENT DISEASE; RISK FACTOR; RURAL AREA; SECONDARY PREVENTION; SMOKING; SOUTH AFRICA; STROKE; SURVIVAL; TRADITIONAL MEDICINE;

CEREBROVASCULAR ACCIDENT; COMMUNITY HEALTH CENTERS; EDUCATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVIEWS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREVALENCE; PREVENTIVE HEALTH SERVICES; PRIMARY NURSING CARE; RISK FACTORS; RURAL HEALTH SERVICES; SOUTH AFRICA; SURVIVORS;

AFRICA; SOUTH AFRICA; SOUTHERN AFRICA; SUB-SAHARAN AFRICA;

EID: 3242779281     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-76.
2. Bonita R. Stroke prevention: a global perspective. In: Norris JW, Hachinski VC, editors. Stoke prevention, 1st edition. New York: Oxford University Press; 2001:259-74.
3. Secondary prevention of noncommunicable diseases in low- and middle-income countries through community-based and health service interventions. Report of WHO-Wellcome Trust Meeting of Experts. Geneva: World Health Organization; 2001.
4. The SASPI Project Team. The prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke. In press 2004.
5. Walker RW, McLarty DG, Masuki G, Kitange HM, Whiting D, Moshi AF, et al. Age specific prevalence of impairment and disability relating to hemiplegic stroke in the Hai District of northern Tanzania. Journal of Neurology, Neurosurgery & Psychiatry 2000;68:744-9.
6. Collinson M, Mokoena O, Mgiba N, Kahn K, Tollman S, Garenne M, et al. Agincourt DSS, South Africa. In: INDEPTH network, editors. Population and health in developing countries, Volume 1. Ottawa: International Development Research Centre; 2002:197-206.
7. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bulletin of the World Health Organization 1976;54:541-33.
8. Lewando-Hundt G, Stuttaford M, Ngoma B, on behalf of SASPI Project team, The social diagnostics of stroke like symptoms: healers, doctors and prophets in Agincourt, Limpopo Province, South Africa. Journal of Biosocial Science. In press 2004.
9. The National Essential Drugs List Committee. South African standard treatment guidelines and essential drugs list for hospital level. Pretoria, South Africa: The National Department of Health; 1998.
10. Hypertension Society of Southern Africa, endorsed by the Medical Association of South Africa and the Medical Research Council. Guidelines for the management of hypertension at primary health care level. South African Medical Journal 1995;85:1321-5.
11. South African Medical Association, Neurological Association of South Africa Stroke Working Group. Stroke therapy clinical guideline. South African Medical Journal 2000;90:276-306.
12. Trostle JA, Hausser WA, Susser IS. The logic of non-compliance: management of epilepsy from the patient's point of view. Culture Medicine & Psychiatry 1993;7:35-56.
13. Hunt LM, Jordan B, Irwin S, Browner, CH. Compliance and the patient's perspective: controlling symptoms in everyday life. Culture Medicine & Psychiatry 1989;13:3315-34.
14. Adome RO, Reynolds Whyte S, Harden A. Popularpills, community drug use in Uganda. Amsterdam: Het Spinhuis; 1996.
15. Rasmussen Za, Rahim M, Streefland P, Hardon A. Enhancing appropriate medicine use in the Karakoram Mountains. Amsterdam: Het Spinhuis; 1996.
16. Lambert, H. Popular therapeutics and medical preferences in rural north India. Lancet 1996;348:1706-9.
17. Feierman S, Janzen J, editors. The social basis of healing in Africa. Berkeley: University of California Press; 1992.
18. Leslie C. Medical pluralism in world perspective. Social Science & Medicine 1980;14B:191-5.
19. Tanner M, Vassoff C. Treatment-seeking behaviour for malaria: a typology based on endemicity and gender. Social Science & Medicine 1998;46:523-32.
20. Vundule C, Mharakurwa S. Knowledge, practices and perception about malaria in rural communities of Zimbabwe: relevance to malaria control. Bulletin of the World Health Organization 1996;74:55-60.
21. Warlow CP; Dennis MS; van Gijn J, Hankey G, Bamford J, Sandercock P, et al. Stroke: a practical guide to management, 2nd edition. Oxford: Blackwell Science; 2001.
22. PROGRESS collaborative group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
23. PATS Collaborating Group. Post-stroke antihypertensive treatment study. A preliminary result. Chinese Medical Journal (English edition) 1995;108:710-7.
24. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
25. Noncommunicable Diseases and Mental Health, World Health Organization. Innovative care for chronic conditions: building blocks for action: global report. Geneva: World Health Organization; 2002. WHO document WHO/NMC/CCH/02.01.